INTRODUCTION {#S1}
============

Cell fate, whether to die, divide, or senesce, is an underlying driver of cancer and disease. Therefore, cell survival is a broadly used metric in a number of contexts in the life sciences. For example, cell viability assays enable basic research studies of molecular pathways and also applied studies of chemical safety. Viability assays are also a mainstay in the pharmaceutical industry, where they are used to predict adverse effects, as well as for establishing efficacy of compounds designed to target cancer cells. Accurate cell survival testing thus plays a significant role in health. For example, in terms of public health, a false negative result for toxicity could lead to people being exposed to a hazardous chemical. For the pharmaceutical industry, a false positive result could mean that an effective drug does not make it to the market, while a false negative result could mean that patients get exposed to toxic pharmaceuticals.

The broadly accepted method for cell survival quantitation is the colony formation assay (CFA) ([@R11]), wherein cells are exposed to an agent and the ability of single cells to form colonies is quantified by eye ([@R17]). While the assay has an impressive dynamic range (over several orders of magnitude), it is inconvenient and relatively low throughput due to the need for 2 to 3 weeks of incubation time. In addition, to prevent colony overlap, cells are plated in large dishes, which require large amounts of media and thus high amounts of test compounds, which can be problematic when studying small molecule libraries, which generally have limited quantities. Further, manual colony counting is time consuming, varies from person to person and lab to lab, and can be prone to bias ([@R11]).

Due to the significant limitations of the CFA, faster viability assays have become popular alternatives. A popular approach is to measure mitochondrial function via metabolism-based endpoints. For example, tetrazolium assays (e.g., 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide \[MTT\] and 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide \[XTT\]) are based upon the underlying principle that a live cell can reduce tetrazolium salts to formazan derivatives, causing a change in color that can be measured by absorbance ([@R3]). Because of their relative ease of use and affordability, tetrazolium assays are commonly used despite their low sensitivity and propensity to artifacts. For example, artifacts can arise from spontaneous reduction of the tetrazolium salts by reducing agents in cell media ([@R11]) or changes in the absorbance induced by pH changes [@R47]). An analogous approach is to quantify intracellular ATP levels ([@R13]). The most popular assay for this approach is the CellTiter-Glo (CTG) assay, wherein luciferin-luciferase luminescence is used to estimate the levels of ATP. Although CTG is exquisitely sensitive, ATP assays are affected by viability-independent perturbations, such as nutrient depletion and pH changes ([@R20]; [@R41]), and can underestimate toxicity for short incubation periods [@R55]). Importantly, as described below, we have also found that CTG can yield highly variable results depending on the initial cell density used in the assay.

Here, we set out to create an alternative approach to cell proliferation analysis that combines several key advantages of existing microtiter plate-based assays with a direct measure of cell division. The result is the "MicroColonyChip" (μCC). For the CFA, the number of cells able to form colonies is used as a metric for cell survival, which is accomplished by counting colonies above a threshold size (estimated by eye). In contrast, for the μCC, the total number of cell divisions is used as a metric of cell survival, which is estimated based on colony sizes (where the number of cells per colony is quantified using a fluorescent DNA stain). Specifically, the μCC approach depends on an alternative metric for cell growth, namely the change in the distribution of microcolony sizes (which reflects the total number of cell divisions). Since colonies are assessed using a microscope, instead of counting by eye, the assay takes 3--5 days instead of 2--3 weeks (note that for both assays, longer times may be required for slower-growing cell types). Furthermore, growing cells in a microarray enables close packing of colonies, while suppressing colony overlap, making it possible to move from large dishes to a 96-well plate format (requiring \~250× less surface area compared to the CFA). Remarkably, the sensitivity of the μCC is nearly identical to the CFA. Furthermore, we find that the μCC is more sensitive than the XTT assay and has comparable sensitivity to CTG, while also being more robust against artifacts caused by culture conditions. Finally, we show that the μCC can be applied to studies of chemical toxicity in metabolically relevant conditions, an important factor for predicting liver toxicity. Taken together, the μCC provides a robust, rapid, automated, and sensitive platform for cell survival quantitation.

RESULTS {#S2}
=======

Patterning of Cells Using a Microwell Array Platform {#S3}
----------------------------------------------------

The μCC is based upon the ability to grow cells in a microarray. Here, we use a cell microarray approach that was previously been described by our laboratory in collaboration with S. Bhatia ([@R60]). Briefly, a polydimethylsiloxane (PDMS) mold (created by photolithography and soft lithography) is pressed into molten agarose. The agarose is allowed to gel, and the mold is removed to create an array of microwells. For the experiments described here, each microwell is \~40 μm in both diameter and depth, spaced 240 μm apart from one another; however, the microwell array platform provides a tunable physical distance between microcolonies and tunable well sizes to accommodate different cell types. A bottomless 96-well plate is then compressed on top of the microwell array to create macrowells, each containing \~300 microwells. Cells are then loaded by gravity and excess cells are removed by sheer force ([Figure 1A](#F1){ref-type="fig"}). Since excess cells can be washed away, the assay is robust across a remarkably broad range of initial cell numbers (2,000--200,000 cells/macrowell). Cells are then trapped by layering low melting point agarose above the cells.

TK6 lymphoblastoid cells are \~15 μm in diameter and can be readily micropatterned with one to seven cells per well at \~40 μm in diameter ([Figure 1B](#F1){ref-type="fig"}). Suspension cells that naturally grow without attachment have previously been shown to form colonies in soft agar ([@R36]; [@R57]). Consistent with these studies, TK6 microcolonies grow on the microwell array platform. The appearance of cells growing out of the microwell boundary was noted as soon as 2 days in culture ([Figure 1B](#F1){ref-type="fig"}, day 2). By day 4, an average microwell harbored a microcolony with more than \~60 cells, which is consistent with a doubling time of \~20 h ([@R18]) and an average of approximately 3 cells/well on day 0 ([Figure 1B](#F1){ref-type="fig"}, day 4).

High-Throughput Quantification of Microcolony Size via Nucleic Acid Fluorescence Staining {#S4}
-----------------------------------------------------------------------------------------

We estimated the number of cells per microcolony based on the total DNA content, using a fluorescence DNA stain that is membrane permeable (Vybrant DyeCycle Green; [Figure 1C](#F1){ref-type="fig"}) ([@R4]). In non-synchronous cultures, the average DNA content per cell stays relatively constant ([@R38]). We imaged microcolonies ([Figure 1D](#F1){ref-type="fig"}) and then used an in-house MATLAB program "uCCanalyzer" ([Data S1](#SD2){ref-type="supplementary-material"}) for microcolony analysis. The "uCCanalyzer" was adapted from previous software ([@R60]) to specifically detect the locations of the microcolonies, generate images of individual microcolonies, and calculate the integrated fluorescence intensity per microcolony (F/M) ([Figure 1E](#F1){ref-type="fig"}).

To explore the efficacy of the F/M parameter, the number of distinct fluorescent nuclei in microcolonies was counted manually as an estimate of the total cell number (examples in [Figure 2A](#F2){ref-type="fig"}). As shown in [Figure 2B](#F2){ref-type="fig"}, the number of cells per microcolony increases linearly with the microcolony's F/M value (*R*^2^ = 0.92, p \< 0.0001; note that the fluorescence level for seven cells is not significantly different from expected, given a linear increase in signal). We found that F/M for a single TK6 cell, or fluorescence intensity per cell (F/C), is 2,300 ± 500 (arbitrary fluorescence unit). To analyze efficacy for larger colonies, we monitored the change in the median F/M value over 4 days in culture. We found that TK6 have a doubling time of \~20 h, which is consistent with what was observed for TK6 cells grown in liquid culture ([Figure 2C](#F2){ref-type="fig"}). We conclude the doubling time of TK6 cells is not significantly affected by culturing in the microarray (as opposed to liquid culture) when analyzed 4 days post plating and that F/M is a sensitive and robust measure of microcolony size (since there is no apparent saturation of signal when analyzed 4 days post plating).

Construction of Microcolony Size Distribution Using F/M Values {#S5}
--------------------------------------------------------------

We monitored the growth of the TK6 microcolonies over the course of 4 days. On each day, a μCC was removed and microcolonies were analyzed for DNA content ([Figure 2D](#F2){ref-type="fig"}). Consistent with the traditional CFA, some microcolonies remained very small, while others had grown extensively. After 4 days, microcolony F/M values ranged from 1 F/C to 150 F/C, corresponding to \~1 cell up to \~150 cells. It is important to note that a colony that initially had 7 cells could readily double to form a colony of more than 150 cells over the course of 4 days (approximately 4.5 doubling times). [Figure 2D](#F2){ref-type="fig"} shows that the F/M distribution of TK6 microcolonies is very tight on day 0 and that as the microcolonies grow, the distribution both shifts to the right and broadens. One can readily see the extent to which the populations become broader when all plots have the same scale for the y axis ([Figure S1A](#SD1){ref-type="supplementary-material"}). We postulate that the broadening of F/M distributions is attributable to the difference in starting microcolony sizes, as well as the rates of cell division and cytotoxicity.

Toxicity Measurement with μCC {#S6}
-----------------------------

To perform a toxicity assay, cells are exposed to a toxic agent for a fixed time and analyzed after at least three cell divisions. As shown in [Figure 2D](#F2){ref-type="fig"}, microcolony growth leads to a shift of the microcolony size distribution toward higher frequencies of larger microcolonies compared to the initial population. [Figure 3A](#F3){ref-type="fig"} illustrates that a toxic treatment (e.g., γ-ionizing radiation \[γIR\]) leads to a much smaller shift, indicating the presence of far fewer surviving cells. Based on this observation, we aimed to measure toxicity by estimating the total number of surviving cells. Specifically, for each microcolony size, we subtracted the relative frequency in the initial population from the relative frequency in the final population. We defined the positive values of the subtractions to be an approximation of the excess microcolonies. For each microcolony size, we multiplied excess microcolonies by the number of cells per microcolony to obtain an estimation of the total number of cells in the excess microcolonies (the total number of surviving cells). A summation of the total number of cells in the excess microcolonies across all available microcolony sizes constitutes excess growth (EG). Thus, EG reflects the extent to which colonies have grown beyond the starting population in size (see hand-drawn illustration in [Figure 3B](#F3){ref-type="fig"}). EG values for each treatment condition are then calculated and compared to a negative control EG (unexposed cells) to obtain percent control growth. In practice, data are analyzed in an automated fashion using "uCCHistogram," a package of in-house Python scripts ([Data S2](#SD3){ref-type="supplementary-material"}).

To explore the sensitivity of EG as a metric for cell survival, we treated micropatterned TK6 cells with γIR. Previous studies using the CFA have shown that TK6 cells are highly sensitive to γIR ([@R2]; [@R59]). We examined the microcolony size distributions for TK6 microcolonies 3 or 4 days after γ-radiation. As shown in [Figure 3A](#F3){ref-type="fig"}, after 3 days, non-irradiated cells gave rise to a broad distribution of microcolony sizes, with approximately a 9-fold increase in median colony size and EG of \~4,000 cells. In contrast, microcolonies that were exposed to 3 Gy of γIR were growth inhibited, due to either cell death or inability to divide, leading to overall smaller microcolonies after 3 days and EG of \~80 cells (note that the final population is nearly overlapping with the starting population).

Having established EG as a parameter for cell survival, we compared it to a more established metric, the median microcolony size. We first used the median colony size to estimate toxicity and found that we could detect about one-log difference in cell survival. Under the exact same conditions, we calculated EG. We found that more than a two-log change in cell survival is detected using EG ([Figure 3C](#F3){ref-type="fig"}). Thus, the intuitive approach of simply comparing median values is relatively ineffective compared to the EG values.

To explore the efficacy of the EG approach for cells with different amounts of total DNA (e.g., different mammalian cell types), we explored whether derivation of F/C is required. Specifically, because F/C is used to estimate EG values, we tested the effect of varying F/C in order to learn about the potential impact of variation in total DNA content per cell. Remarkably, EG is robust against a 25-fold range of F/C values ([Figure S1B](#SD1){ref-type="supplementary-material"}; note that F/C = 2,300 was derived from the standard curve for TK6 in [Figure 2B](#F2){ref-type="fig"}), obviating the need for re-deriving F/C for different mammalian cell types. Therefore, for all subsequent studies, all the microcolony size distributions are analyzed for EG values using F/C = 2,300, and the method will simply be referred to as "μCC."

Radiosensitivty of Cancer Cells: Comparison of μCC, XTT, CTG, and CFA {#S7}
---------------------------------------------------------------------

To investigate the sensitivity of the μCC for measuring γIR-induced toxicity, we compared its performance to that of several other assays. Specifically, we compared μCC with the CFA ([@R18]; [@R42]) and two commercially available methods, XTT and CTG. For the CFA, we tracked the appearance of colonies in 96-well plates over 18 days and observed that some colonies were not obvious until the last day ([Figure S2](#SD1){ref-type="supplementary-material"}). Therefore, we decided on a timescale of 3 weeks before counting the colonies in order to maximize the assay's sensitivity. In contrast, the μCC data were obtained 3 days after γIR. Remarkably, we observed that the μCC yields an exponential toxicity curve that is virtually undistinguishable from the survival curve obtained from the CFA ([Figure 4A](#F4){ref-type="fig"}). We then specifically compared the μCC results to a study performed in 1998 ([@R59]) using the same cell type but analyzed using the traditional CFA. Interestingly, the μCC assay also yielded nearly identical results to the historic data ([Figure 4B](#F4){ref-type="fig"}). We conclude that the μCC assay is as sensitive as the CFA, while being far faster (3 days versus 3 weeks).

Many microtiter-plate methods for measuring cell viability have been developed as faster and more convenient alternatives to the CFA. We therefore sought to compare the μCC with two of the most popular assays, XTT and CTG. The XTT method is a widely used colorimetric assay that estimates the number of viable cells by measuring the ability of cells to reduce the faint yellow salt (XTT) to a bright orange water-soluble formazan dye ([@R52]). Remarkably, the μCC assay is orders of magnitude more sensitive than the popular XTT assay ([Figure 4C](#F4){ref-type="fig"}).

The CTG assay (from Promega) is based on luminescent quantification of cellular ATP, which is proportional to the number of metabolically active cells ([@R13]). We found that when using 400 cells per well on a 96-well plate, the CTG assay and the μCC assay yield comparable results (compare [Figure 4D and Figure 4E](#F4){ref-type="fig"}). Flowever, unexpectedly, the CTG results are highly dependent on the initial cell number ([Figure 4D](#F4){ref-type="fig"}; [Figure S3A](#SD1){ref-type="supplementary-material"}). Thus, results can potentially vary considerably from one experiment to the next if the concentration of cells is not optimized. Unlike CTG, the μCC is highly consistent across a two-log range of cell loading densities ([Figure 4E](#F4){ref-type="fig"}; [Figure S3B](#SD1){ref-type="supplementary-material"}). Importantly, the number of days in culture also changes the results of CTG, while having a minimal effect on the μCC ([Figure S3](#SD1){ref-type="supplementary-material"}).

Use of μCC as a Tool for Study of DNA Repair in Chemotherapeutic Sensitivity {#S8}
----------------------------------------------------------------------------

There is a great interest in DNA damaging agents, because they can both cause cancer and be used to treat cancer. Here, we explored the utility of the μCC as a tool for studies of the role of DNA repair in preventing cytotoxicity caused by two DNA damaging agents used for cancer chemotherapy, namely γIR and N,N'-bis (2-chloroethyl)-N-nitrosourea (BCNU). BCNU, a chemotherapeutic alkylating agent used to treat brain cancers ([@R14]; [@R34]; [@R57]), induces highly cytotoxic DNA interstrand crosslinks ([@R29]). DNA crosslinks are formed when *O*^6^-chloroe-thylguanine lesions form an ethano ring that can then react with cytosine to form an interstrand crosslink ([@R56]). The *O*^6^-methylguanine DNA methyltransferase (MGMT) protein removes the *O*^6^-chloroethyl adducts and thus prevents ethano lesions from forming crosslinks ([@R25]; [@R39]).

TK6 cells are deficient in MGMT and are very sensitive to BCNU toxicity, while TK6 cells stably transfected with cDNA expressing the MGMT protein (designated as MGMT in [Figures 5A and 5B](#F5){ref-type="fig"}) are resistant to BCNU ([@R25]; [@R40]; [@R57]). As a control, we studied the effects of γIR, for which MGMT is not expected to play a role. Results show that TK6 and TK6+MGMT are similarly sensitive to γIR ([Figure 5A](#F5){ref-type="fig"}), consistent with the fact that MGMT is not involved in the repair of γIR-induced DNA damage. In contrast, TK6+MGMT displays vastly increased resistance to BCNU compared to MGMT-deficient TK6 cells, as expected ([Figure 5B](#F5){ref-type="fig"}). These results again show that the μCC accurately recapitulates results obtained using the gold standard CFA ([@R57]).

Application of μCC to Test for Chemical Toxicity under Metabolically Relevant Conditions {#S9}
----------------------------------------------------------------------------------------

In the human body, foreign chemicals are extensively metabolized, mainly by hepatocytes in the liver ([@R28]). This process can result in reactive intermediates that form mutagenic and cytotoxic DNA adducts ([@R44]). While viability assays are widely used to monitor the potential health impact of industrial and pharmaceutical chemicals, a major drawback is the use of cells that lack metabolic capacity. The cytochrome P450s (CYP450s) are a superfamily of metabolizing enzymes, responsible for \~70%--80% of phase I metabolism in the liver ([@R16]). Here, we employed metabolically competent cell lines, MCL-5 and HepG2. MCL-5 is a human B-lymphoblastoid cell line engineered to stably express human cytochrome P450 CYP1A1, CYP1A2, CYP2A6, CYP2E1, and CYP3A4 ([@R12]). Together, these metabolic enzymes are responsible for approximately 50% of P450 activity in phase I metabolism ([@R16]). HepG2 is a human hepatocyte cell line derived from hepatocellular carcinoma. HepG2 cells retain partial liver-specific functions, including relatively high expressions of the CYP1 family (CYP1A1, CYP1A2, and CYP1B1) and are a classic cell model for metabolism studies ([@R8]).

Millions of people worldwide are exposed to aflatoxin B~1~ (AFB~1~), a procarcinogen that can be metabolized in the liver to form a potent liver carcinogen. AFB~1~ is present in the molds *Aspergillus flavus* and *A. parasiticus,* which can be found on grains. Genotoxic metabolites are generated via oxidation of AFB~1~ mainly by CYP3A4 and CYP1A2 ([@R19]). We applied the μCC to measure the toxicity of AFB~1~ in MCL-5 cells. To control for the effects of metabolism, we included TK6 as a negative control cell line, since it lacks expression of phase I enzymes. As expected, MCL-5 cells are significantly more sensitive than TK6 ([Figure 6A](#F6){ref-type="fig"}). Further, we confirmed that MCL-5's sensitivity to AFB~1~ is due to metabolic activation of AFB~1~ by using ketoconazole (KET), a potent inhibitor of CYP3A4 activity ([@R30]). Whereas MCL-5 cells are extremely sensitive to AFB~1~, inhibition of metabolism by KET efficiently suppresses this sensitivity ([Figure 6B](#F6){ref-type="fig"}).

In metabolism studies, HepG2 is one of the most commonly used cell lines. Therefore, to further demonstrate the utility of the μCC, we applied the assay in HepG2 cells to measure the toxicity of benzo\[a\]pyrene (B\[a\]P), another human procarcinogen. Most people are exposed to B\[a\]P daily via breathing in fuel exhaust, cigarette smoke, or consuming charred food ([@R37]). B\[a\]P is metabolized in the liver mainly by the CYP1 family to form highly carcinogenic metabolites ([@R37]). Because HepG2 is an adherent cell type, we incorporated a layer of collagen type 1 into the μCC to enable cell attachment. The HepG2 microcolonies were cultured in the presence of B\[a\]P for 5 days and then assessed for toxicity. In order to control for the effect of B\[a\]P metabolism, we used α-naphthoflavone (ANF), a potent inhibitor of CYP1A2 ([@R9]). As expected, while HepG2 is highly sensitive to B\[a\]P, the suppression of B\[a\]P metabolism via ANF makes the cells completely resistant ([Figure 6C](#F6){ref-type="fig"}). Taken together, the incorporation of metabolically competent cells, such as MCL-5 and HepG2, into the μCC platform yields a rapid, sensitive, and physiologically relevant method for chemical toxicity testing.

DISCUSSION {#S10}
==========

Despite the fact that a large number of cytotoxicity tests are performed every year worldwide, there have been relatively few fundamental advances in cytotoxicity assays in recent decades. Although having been developed decades ago, the CFA is still the most broadly accepted method for cell survival. Major drawbacks of the assay include its low throughput and laborious procedure as well as incompatibility with high-throughput screening. Alternative faster approaches have been developed, but they rely on indirect measures of cell viability. With nearly identical sensitivity, we show here that the μCC rivals the CFA with its speed and automation and thus presents a valuable alternative. The results presented in this work highlight a few important advantages of the μCC assay, as follows: (1) analysis of microcolony size distribution is a direct measure of cells' ability to divide, enabling quantification of cell survival in \~3--5 days (instead of \~2--3 weeks for the CFA); (2) by arraying cells in microwells, the μCC shrinks the area needed for cell growth to \~1/250 of the area needed for the CFA, enabling compatibility with the microtiter 96-well plate format; (3) the μCC is capable of measuring cell survival on a multi-log scale, enabling sensitive quantification of toxicity; and (4) the μCC is robust against experimental noise introduced by differences in initial cell numbers, unlike CTG. Perhaps the most important observations are that results from the μCC are nearly identical to data from the traditional CFA performed in our laboratory as well as to data collected using the same approach \~20 years ago by leading toxicology laboratories ([@R33]; [@R57]; [@R59]).

Today, common approaches for measuring cell viability are the tetrazolium and ATP assays. The underlying principle for these assays is that the number of viable cells is estimated by the cells' mitochondrial functions, either to reduce a tetrazolium salt or to maintain intracellular ATP level. Although tetrazolium assays have enjoyed popularity due to the convenient microtiter plate format, they suffer from limited sensitivity ([@R6], [@R7]; [@R11]). In contrast, as demonstrated in this work, the μCC is capable of measuring multi-log survival levels in the same amount of time and is more sensitive than the XTT assay, one of the most common tetrazolium assays. Importantly, the μCC relies solely on DNA content, which is a reliable and robust measure of cell number ([@R4]; [@R38]; [@R48]; [@R49]). In contrast, tetrazolium assays depend on mitochondrial activity, which can vary due to factors unrelated to cell division ([@R11]; [@R46]; [@R47]).

Similar to tetrazolium assays, ATP assays are also a staple in cell viability testing. The CTG assay is amendable to microtiter plate format and is highly sensitive, and the luminescence output is very convenient to measure. In this work, we observed that CTG results are highly variable depending on both initial cell number and the number of days in culture. This is in sharp contrast to the μCC assay, which is consistent across more than two orders of magnitude variation in initial cell number and number of days in culture. The observed dependence of the CTG assay on initial cell number is consistent with the fact that metabolic functions are highly influenced by non-lethal changes in culture conditions ([@R20]; [@R41]; [@R45]; [@R46]; [@R55]). In addition, the relationship between intracellular ATP level and cell viability is not always linear ([@R35]). Finally, ATP-based assays are not appropriate to assess toxicity of chemicals that might interfere with ATP biosynthesis (e.g., atractyloside inhibits ADP/ATP translocases, inhibiting ATP biosynthesis) ([@R51]).

The μCC has several important advantages compared to the traditional CFA. In particular, the CFA requires that colonies above 50 cells/colony be counted by eye. Counting colonies is prone to bias, vulnerable to inter-laboratory differences (since it is necessary to decide if a colony is countable or not), and laborious. By using image analysis software, bias is eliminated and inter-laboratory differences are suppressed. In terms of labor, with the exceptions of casting the gel (\~10 min of labor) and that colony counting is replaced by imaging and image analysis, the remaining steps are similar. Depending on the density of colonies, counting colonies for a single experiment can take many hours. In contrast, imaging takes minutes, and analysis can be performed rapidly using in-house software. Thus, the μCC has advantages beyond the difference of incubation time (weeks versus days), since the μCC reduces bias, inter-laboratory variability, and labor.

For the μCC approach, microcolony size reflects the ability of cells to divide between one and four times post exposure. Thus, quantitation of early cell division events is an effective predictor of colony forming ability, as revealed by the CFA. Interestingly, both approaches are impacted by cell cycle arrest and delayed cell death, which can give rise to smaller colonies. For the μCC, fewer cells would be present, whereas for the CFA, colonies may be too small to count (for the CFA, colonies with fewer than 50 cells are not counted). Thus, both assays are sensitive to arrest and delayed cell death. Importantly, using an independent approach, it was previously shown in the Samson laboratory that estimates of the number of cells that divide once, twice, or three times post exposure yield results comparable to the CFA ([@R57]). Thus, quantification of early cell division events post exposure is an effective predictor of toxicity when estimated by the CFA, even though the basis for the assays is somewhat different (ability of cells to divide for the μCC and ability of a cell to form a colony for the CFA).

The advantages of the μCC over commonly used cell viability assays can be leveraged to provide an efficient and sensitive screening platform in drug discovery. Quantification of cell proliferation provides a critical endpoint for discovery of effective cancer treatments. For example, in cancer therapy research, large chemical libraries are screened for their ability to induce toxicity in cancer cells ([@R5]). On the other hand, compounds are also selected for their ability to stimulate cell growth, which is relevant for tissue repair and certain medical procedures, such as hematopoietic regeneration after bone marrow transplantation ([@R61]). In these cases, the μCC can provide an effective screening platform to select candidate drugs that stimulate cell division.

In drug development, it is also important to understand the underlying cell death mechanism induced by a potential candidate. Specifically, cell death modalities, such as apoptosis and necrosis, can be exploited as therapeutic targets. For example, necrosis inducers can be used to target apoptosis-resistant tumors ([@R20]; [@R31]). Further, the μCC can potentially be used in a multiplex fashion to both assess cytotoxicity and study cell death mechanism. For example, in addition to EG, we have shown that established viability biomarkers, such as plasma membrane integrity (ethidium homodimer staining), esterase activity (calcein acetoxymethyl \[AM\] staining), and apoptosis (Annexin V staining) can be probed simultaneously to provide information about cytotoxic levels as well as cell death modalities ([Figure S4](#SD1){ref-type="supplementary-material"}).

In the broad context of chemical toxicity testing, a major limitation of cell-based assays is the lack of metabolic activation ([@R10]). Therefore, *in vitro* assays need to account for the toxic effects of both the parent chemicals and their metabolites ([@R10]). By employing MCL-5 and HepG2 cells, which have stable expression of critical metabolic enzymes, the μCC can provide a rapid and sensitive platform for compounds that require metabolic activation.

The μCC's compatibility with the microtiter plate format is potentially adaptable for high-throughput screening (HTS) for chemical safety testing in the context of environmental health. Due to the large number of chemicals that come in contact with humans and the environment, governmental agencies, such as the U.S. National Toxicology Program and the EU's Registration, Evaluation, Authorisation, and Restriction of Chemicals, have heavily invested in large-scale chemical safety studies. Cell sensitivity is a critical endpoint in these studies, and microtiter plate viability assays are often the top choice due to their compatibility with HTS. With its many advantages, the μCC could provide more accurate assessment of cytotoxicity in these contexts.

In this work, we mainly focused on lymphoblastoid cells that can grow in suspension. Many different cell types can similarly be grown in a non-adherent fashion, making them compatible with the agarose-based μCC platform. However, for some cell types, a charged surface or a biological ligand is needed for adherent growth in culture ([@R27]; [@R32]). We have explored the potential utility of additives to make the μCC effective for adherent cells. For example, cells loaded into the agarose microwells can be overlaid with collagen type 1 followed by low melting point agarose. We found that HeLa cells and HepG2 cells appear to attach to the collagen ligands and form adherent microcolonies ([Figure S5](#SD1){ref-type="supplementary-material"}, top and middle). Further, we showed that HepG2 cultured on the collagen-modified μCC are highly sensitive to B\[a\]P ([Figure 6C](#F6){ref-type="fig"}), demonstrating that μCC can be used to study toxicity cells that are normally cultured on tissue culture plastic. Other extracellular matrix component proteins including laminin 1, fibronectin, vitronectin, and various collagens ([@R24]) can also potentially be added to the μCC. Additionally, microwell diameters and distances between the microwells can be varied to accommodate different cell types. For example, for larger cells, a microwell with a larger diameter may be desirable, and for cells that migrate away from the microcolony (such as fibroblasts), an increase in the inter-microwell distance may be advantageous.

Because of its high-throughput capacity and its multi-log sensitivity, we also anticipate that the μCC platform can be applied to personalized medicine, as well as to studies of environmental chemicals. For personalized medicine, it is possible that for many cancers, tumor cells could be cultured on the μCC, since anchorage-independent growth is a characteristic of many cancer cells. As such, it may be possible to culture cells from a biopsy on the μCC in order to predict responses of primary cancer cells to anticancer drugs ([@R50]). In terms of differences in sensitivity for normal cells, many studies have revealed interindividual differences in radiosensitivity among mitogen-stimulated T lymphocytes obtained from different individuals ([@R23]). We expect that the μCC is well suited for studies of toxicity in normal and cancer cells, in part because of its ability to yield sensitive measurements after only a few days in culture.

In conclusion, we have developed the μCC, a rapid and sensitive cell survival assay that combines key advantages of commonly used viability assays with an alternative metric for cell division, namely colony size distribution. With the short assay time and large dynamic range, the μCC platform provides a more rapid alternative to the CFA, which continues to be the most broadly accepted method in cell survival testing. The companion publicly available software enables automated image analysis of thousands of microcolonies in a few minutes, making it easy for a new user to learn and use the assay. Finally, the high-throughput and potential multiplexing capacity make the μCC a powerful tool for many applications, including screens for drug development, epidemiological studies, and chemical safety studies.

STAR★METHODS {#S11}
============

Detailed methods are provided in the online version of this paper and include the following:

CONTACT FOR REAGENT AND RESOURCE SHARING {#S12}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Bevin P. Engelward (<bevin@mit.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S13}
--------------------------------------

### Cell Lines {#S14}

TK6 ([@R43]; [@R53]), TK6+MGMT ([@R33]), and MCL-5 ([@R12]) human B-lymphoblastoid cell lines were cultured in 1X RPMI 1640 medium with GlutaMAX^™^ supplemented with 10% FBS and 100 U/ml Pen-Strep. Human liver carcinoma-derived HepG2 ([@R1]) (ATCC® HB-8065) cell line was obtained from the American Type Culture Collection (Manassas, VA). HepG2 cells were cultured in high-glucose DMEM supplemented with 10% FBS, 1X GlutaMAX, and 100 U/ml Pen-Strep. Human skin fibroblast ([@R15]; [@R54]) cell line was cultured in high-glucose DMEM supplemented with 10% FBS, 2 mM L-glutamine, and 100 U/ml Pen-Strep. HeLa ([@R26]) cells were cultured in high-glucose DMEM supplemented with 10% FBS and 100 U/ml Pen-Strep. TK6, TK6+MGMT, MCL-5, HepG2, and human skin fibroblast cells were derived from male patients, and HeLa cells were derived from a female patient. The cell lines have not been authenticated. All cells were cultured at 37°C with 5% atmospheric CO~2~.

METHOD DETAILS {#S15}
--------------

### μCC Fabrication {#S16}

Microwells were fabricated as described previously ([@R21], [@R22]; [@R58]; [@R60]). Briefly, 1% w/v agarose solution in phosphate-buffered saline (PBS) was prepared. When the molten agarose solution cooled down to \~65°C, Pen-Strep was aseptically added to a final concentration of 200 U/ml. A polydimethylsiloxane (PDMS) mold with an array of micropegs was pressed into the molten agarose solution on top of the hydrophilic side of a sheet of GelBond® Film (Lonza, Hopkinton, MA). The agarose was allowed to gelate at room temperature for \~15 minutes. After the mold was removed, a bottomless 96-well plate was pressed on top of the agarose chip to create 96 wells, each with \~300 microwells at its base.

A 0.6% w/v low melting point agarose stock solution in PBS was kept molten at 43°C. A culture medium stock (RPMI 1640 with GlutaMAX^™^ supplemented with 20% FBS and 200 U/ml Pen-Strep) was kept at 37°C. To prepare the 0.3% w/v overlay agarose solution, one volume of the agarose stock solution was combined with one volume of the culture medium stock. Cells were loaded into the microwells by gravity, and the gel was then covered with 0.3% w/v overlay agarose, prepared as described above. After 15 min at room temperature (RT), another layer of the overlay agarose was added. After another 15 min at RT, the gel was transferred to 4°C for 15 min to ensure maximal gelation of the overlayed agarose.

The RatCol® Collagen Solution kit (5153-1KIT) was purchased from Advanced BioMatrix, Inc., San Diego, CA. A solution of collagen type 1 was prepared on ice according to the manufacturer's 3-D gel preparation procedure using the supplied neutralization solution and was diluted in culture medium to a final concentration of 1 mg/ml collagen. For HepG2, HeLa, and human skin fibroblasts, after the cells were loaded into the microwells, the agarose gel was covered with a thin layer of the 1 mg/ml collagen solution. After 15 min at RT and 15 min at 37°C (for maximal collagen gel formation), a thin layer of 0.3% w/v overlay agarose was added on top of the collagen gel layer. The gel was further incubated for 15 min at RT, followed by 15 min at 4°C.

### Microcolony Culture and Treatment with DNA Damaging Agents {#S17}

The μCC was incubated in fresh culture medium at 37°C and 5% atmospheric CO~2~ overnight. The μCC was then either exposed to γIR or submerged in treatment solutions (Note that an effective alternative is to treat cells prior to loading the μCC.).

### Cell Fixation {#S18}

The μCC was submerged in 10% formalin and kept at 4°C for at least 2 hours.

### Treatment with γIR {#S19}

The μCC was exposed to γ-rays from a ^137^Cesium source at 1 Gy/min (Gammacell 40 Exactor, Best Theratronics Model C-440). Following irradiation, the μCC was submerged in culture medium and incubated at 37°C and 5% atmospheric CO~2~ for three or four days before fixation.

### BCNU Treatment {#S20}

The μCCs were removed from culture medium and rinsed by submerging in PBS for 5 minutes. PBS was aspirated and replaced with BCNU diluted in warm RPMI 1640 (+ GlutaMAX^™^) supplemented with 100 U/ml Pen-Strep. The maximum final concentration of ethanol was 0.1%. BCNU exposure was for one hour at 37°C with 5% atmospheric CO~2~. BCNU solution was aspirated and residual BCNU was rinsed off twice by submerging the μCC in PBS for 5 minutes each time. Following exposure, the μCC was submerged in culture medium and incubated at 37°C and 5% atmospheric CO~2~ for three days before fixation.

### AFB~1~ Treatment {#S21}

The μCC was incubated in AFB~1~ solution for 24 hours at 37°C and 5% atmospheric CO~2~. The maximum final concentration of DMSO was 0.5%. After 24 hours, the AFB~1~-supplemented medium was removed, and the μCC was washed three times by submerging in PBS for 5 minutes each time. Following exposure, the μCC was submerged in culture medium and incubated at 37°C and 5% atmospheric CO~2~ for three days before fixation.

### Inhibition of AFB~1~ Metabolism with KET {#S22}

To inhibit AFB~1~ metabolism, 5 μM KET was added to culture medium at the start of AFB~1~ treatment. The maximum final concentration of DMSO was 0.5%.

### B\[a\]P Treatment {#S23}

The μCC was incubated in B\[a\]P solution for five days at 37°C and 5% atmospheric CO~2~. The maximum final concentration of DMSO was 0.003%. The μCC was fixed immediately following exposure.

### Inhibition of B\[a\]P Metabolism with ANF {#S24}

To inhibit B\[a\]P metabolism, 25 μM ANF was added to culture medium at the start of B\[a\]P treatment. The maximum final concentration of DMSO was 0.1%.

### Imaging and Analysis {#S25}

After cell fixation, the μCC was stained with Vybrant® DyeCycle^™^ Green (dissolved in PBS to a final concentration of 1.5 μM) at 4°C overnight, protected from light. Fluorescent images were captured using an epifluorescence microscope (Nikon Eclipse 80i, Nikon Instruments, Inc., Melville, NY) with a 480 nm excitation filter and a fixed aperture time. Images were analyzed using "uCCanalyzer" ([Data S1](#SD2){ref-type="supplementary-material"}), a freely available custom software written in MATLAB (The MathWorks Inc., Natick, MA), as previously described ([@R60]), except with modifications to enable quantification of F/M. Distributions of F/M values were generated and exported into spreadsheet files using "uCCHistogram" ([Data S2](#SD3){ref-type="supplementary-material"}), a package of custom scripts written in Python (Python Software Foundation, Python version 2.7.10). Analyses of F/M distributions were performed in Microsoft Excel (Microsoft Office Suite 2016).

### Correlation of F/M Values with Cell Numbers per Microwell {#S26}

TK6 cells were loaded onto a μCC and stained with Vybrant® DyeCycle Green. The number of distinct fluorescent nuclei was counted manually and compared to the F/M value of the corresponding microwell to determine fluorescence/cell (F/C).

### Calculation of Percent Control Growth {#S27}

F/M is used to approximate microcolony size, which is then used to construct microcolony size distributions. For each microcolony size, we subtracted the relative frequency in the initial population from the relative frequency in the final population. We defined the positive values of the subtractions to be an approximation of the excess microcolonies. For each microcolony size, we multiplied the approximate excess microcolonies by the number of cells per microcolony to obtain an estimation of the total number of cells in the excess microcolonies. EG is calculated by adding the total number of cells in the excess microcolonies across all available microcolony sizes. The EG value for each treatment condition was calculated and compared to a negative control EG (unexposed cells) to obtain percent control growth. In practice, data is analyzed in an automated fashion, using uCCHistogram.

### CFA in Microtiter Plates {#S28}

The CFA was performed as previously described ([@R18]; [@R42]). Briefly, TK6 cells growing in suspension were exposed to γIR and then distributed over U-bottom 96-well plates. After three weeks, wells were scored for the absence of colony growth, and the surviving fraction was then calculated ([@R18]; [@R42]). Phase-contrast pictures were taken with an Olympus TG-860 Tough Stylus Digital Camera (Olympus America, Inc., Center Valley, PA) at 5X magnification.

### XTT Assay {#S29}

The XTT kit was purchased from Cell Signaling Technology® (Danvers, MA). Three days after μIR treatment, the viability of TK6 cells was measured according to the manufacturer's instructions.

### CTG® Assay {#S30}

The CTG® kit was purchased from Promega (Madison, WI). Three or four days after μIR treatment, the viability of TK6 cells was measured according to the manufacturer's instructions.

### Live/Dead Staining {#S31}

The LIVE/DEAD® Viability/Cytotoxicity kit for mammalian cells was obtained from Thermo Fisher Scientific (Waltham, MA). The μCC was rinsed three times by submergence in fresh 1X PBS for 5 minutes. A solution of calcein-AM and ethidium homodimer-1 (EthD-1) was prepared according to the manufacturer's instruction such that the final concentrations for calcein-AM and EthD-1 were 2 μM and 4 μM, respectively. The μCC was then submerged in the calcein-AM/EthD-1 solution and incubated at 37°C for 1 hour, protected from light. Microcolonies were imaged with an epifluorescence microscope using 480 nm and 560 nm excitation filters for calcein and EthD-1, respectively.

### Apoptosis Staining {#S32}

A Tali® Apoptosis kit was purchased from Thermo Fish Scientific (Waltham, MA). The μCC was rinsed three times via submergence in 1X Annexin binding buffer for 5 minutes. Annexin V Alexa Fluor® 488 stock solution was diluted 1:20 in 1X Annexin binding buffer. The final solution was used to completely cover the μCC. After 30 minutes of incubation at 37°C (protected from light), EthD-1 stock solution from the LIVE/DEAD® Viability/Cytotoxicity kit was added to a final concentration of 4 μM. After incubation at 37°C for 30 minutes, microcolonies were imaged with 480nm and 560nm excitation filters for Annexin V and EthD-1, respectively.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S33}
---------------------------------------

### Statistical Analysis {#S34}

All statistical details of experiments can be found in the figure legends, where n represents the number of independent experiments. All experiments were repeated at least three times. At least 700 microcolonies were analyzed per condition. The Student's t test was used to evaluate significance (p \< 0.05). Error bars (SEM) and curve fitting were performed using GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla California USA, <https://www.graphpad.com>.

DATA AND SOFTWARE AVAILABILITY {#S35}
------------------------------

MATLAB software "uCCanalyzer" for quantification of F/M: [Data S1](#SD2){ref-type="supplementary-material"}.

Python script package "uCCHistogram" for generating F/M distributions and importing to Microsoft Excel: [Data S2](#SD3){ref-type="supplementary-material"}.
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![Construction of μCC and Quantification of Total DNA Content\
(A) Micropatterning cells in μCC. (1) APDMS stamp with microposts is pressed into molten agarose; (2) agarose is allowed to cool and gelate; (3) stamp is lifted to reveal patterned microwells on agarose; (4) cell suspension is added; (5) cells settle into microwells via gravity, and excess cells are washed off via sheer force; and (6) cells are trapped by an overlay of 0.3% low melting point agarose.\
(B) Phase-contrast images of patterned TK6 microcolonies (40x magnification). Far left: empty agarose microwell array. Day 0: micropatterned cells after loading. Day 1 to day 4: images of microcolonies after growth for the indicated time.\
(C) Phase-contrast image of a TK6 microcolony after 4 days in culture.\
(D) A fluorescent image of a different TK6 microcolony stained with Vybrant DyeCycle Green.\
(E) A plot of the average fluorescence intensity of each pixel column from the left to the right of the colony shown in (D), after background correction (binary mask using Otsu thresholding method). F/M is the total area under the curve.\
All scale bars, 100 μm.](nihms-1523257-f0002){#F1}

![Total DNA Content as a Measure of Microcolony Size\
(A) Calculation of F/M for microwells with one cell (left) and five cells (right). Top: fluorescent images of TK6 cells stained with Vybrant DyeCycle Green. Bottom: fluorescence intensity plots of the corresponding fluorescent images. Scale bars, 100 μm.\
(B) Average F/M values for one to seven TK6 cells. Dotted black line = linear fit of data (*R*^2^ = 0.92, p \< 0.0001).\
(C) Fold change of median F/M for TK6 microcolonies in μCC (green) and TK6 cell density in liquid culture (red). Dotted lines = exponential fits of data (*R*^2^ = 0.99 for both).\
(D) TK6 microcolony size distributions. F/M values of \>700 microcolonies were analyzed for each distribution and converted to cell numbers by dividing by the value of one F/C. The y axis for each plot is individually scaled.\
In (B) and (C), all data are means of at least three independent experiments (n ≥ 3). Error bars are SEM.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1523257-f0003){#F2}

![Comparison of Microcolony Size Distributions for Toxicity Assessment\
(A) TK6 microcolony size distributions. Left: distribution before γIR (starting population, gray) overlaying with untreated distribution after 3 days in culture (untreated, green). Right: distribution before γIR (starting population, gray) overlaying with γ-irradiated distribution after 3 days in culture (3 Gy, green).\
(B) Illustration of microcolony size distributions before (starting population, gray) and after growth (final population, green). EG is the total number of cells in excess microcolonies (magenta outlined).\
(C) μIR-induced toxicity (% control growth) derived from normalization of γ-irradiated microcoionies by "untreated" distribution using median microcolony sizes or EG. n ≥ 3. Error bars are SEM.](nihms-1523257-f0004){#F3}

![Comparisons among Toxicity Assays for TK6 Cells Exposed to γIR\
(A) Data from CFA (light blue) and μCC (green).\
(B) CFA data obtained from [@R59] (black) were reproduced with permission from *Radiation Research.*\
(C) Data from XTT (dark blue).\
(B and C) The μCC data are the same as in (A).\
(D) CTG data were obtained from different cell seeding densities.\
(E) The μCC data were obtained from different cell loading densities.\
n ≥ 3. Error bars are SEM.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1523257-f0005){#F4}

![Application of μCC to Study the Role of DNA Repair Protein in Mediating Toxicity Induced by DNA Damaging Agents\
(A) γIR treatment for TK6 and TK6+MGMT (labeled MGMT).\
(B) BCNU treatment for TK6 and TK6+MGMT. \*p \< 0.05, Student's t test, two-tailed, unequal variance. n ≥ 3. Error bars are SEM.](nihms-1523257-f0006){#F5}

![Application of μCC to Study Toxicity Induced by Metabolic Activation in Metabolically Competent Cell Lines\
(A) AFB~1~ exposure for TK6 and MCL-5. \*p \< 0.05, Student's t test, two-tailed, unequal variance.\
(B) Treatment of MCL-5 cells with AFB~1~ alone or in the presence of 5 μM KET.\
(C) Treatment of HepG2 cells with B\[a\]P alone or in the presence of 25 μM ANF.\
In (B) and (C), \*p \< 0.05, Student's t test, two-tailed, paired. n ≥ 3. Error bars are SEM.](nihms-1523257-f0007){#F6}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                             SOURCE                                                IDENTIFIER
  ----------------------------------------------- ----------------------------------------------------- -------------------------------------------------------
  Biological Samples                                                                                    
  Fetal bovine serum                              Atlanta Biologicals                                   Cat\#S11150
  Chemicals, Peptides, and Recombinant Proteins                                                         
  1,3-Bis(2-chloroethyl)-1-nitrosourea            Sigma-Aldrich                                         Cat\#C0400
  aflatoxin B~1~                                  Sigma-Aldrich                                         Cat\#A6636
  ketoconazole                                    Sigma-Aldrich                                         Cat\#K1003
  benzo\[a\]pyrene                                Sigma-Aldrich                                         Cat\#B1760
  dimethyl sulfoxide                              Sigma-Aldrich                                         Cat\#D45040
  alpha-naphthoflavone                            Sigma-Aldrich                                         Cat\#N5757
  Vybrant DyeCycle Green                          Thermo Fisher Scientific                              Cat\#V35004
  RPMI 1640 medium                                Thermo Fisher Scientific                              Cat\#61870-036
  DMEM medium                                     Thermo Fisher Scientific                              Cat\#11965092
  GlutaMAX                                        Thermo Fisher Scientific                              Cat\#35050061
  Penicillin-Streptomycin                         Thermo Fisher Scientific                              Cat\#15140-122
  10% formalin solution                           Thermo Fisher Scientific                              Cat\#5755
  Critical Commercial Assays                                                                            
  XTT cell viability kit                          Cell Signaling Technology                             Cat\#9095
  CellTiter-Glo                                   Promega                                               Cat\#G7570
  LIVE/DEAD Viability/Cytotoxicity kit            Thermo Fisher Scientific                              Cat\#L3224
  Tali Apoptosis kit                              Thermo Fisher Scientific                              Cat\#A10788
  Experimental Models: Cell Lines                                                                       
  Human: TK6 cells                                W. G. Thilly ([@R43]; [@R53])                         N/A
  Human: MCL-5 cells                              G. J. Jenkins ([@R12])                                N/A
  Human: TK6+MGMT cells                           L. D. Samson ([@R33])                                 N/A
  Human: HepG2 cells                              ATCC                                                  HB-8065
  Human: HeLa cells                               ATCC                                                  CCL-2
  Human skin fibroblasts                          O. D. Scharer ([@R15]; [@R54])                        N/A
  Software and Algorithms                                                                               
  uCCAnalyzer                                     This paper, modified from guicometanalyzer ([@R60])   N/A
  uCCHistogram                                    This paper                                            N/A
  Prism 6.0                                       GraphPad Software                                     <https://www.graphpad.com/scientific-software/prism/>
  Microsoft Excel                                 Microsoft                                             Microsoft Office Suite 2016
  Other                                                                                                 
  RatCol Collagen Solution kit                    Advanced BioMatrix                                    Cat\#5153-1KIT
  ^137^Cesium γ-rays                              Best Theratronics                                     Gammacell 40 Exactor
  GelBond Film                                    Lonza                                                 Cat\#53761
  UltraPure Agarose                               Thermo Fisher Scientific                              Cat\#16500500
  UltraPure Low Melting Point Agarose             Thermo Fisher Scientific                              Cat\#16520050

###### Highlights

-   The MicroColonyChip (μCC) is a rapid cell survival quantitation platform

-   Colony micropatterning enables 250× miniaturization of the colony formation assay

-   Analysis of microcolony sizes enables rapid automated analysis of cell survival

-   μCC is more sensitive and robust than commonly used cytotoxicity assays
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